Caris Life Sciences, Inc. (CAI)
16.96
+0.82
(+5.08%)
USD |
NASDAQ |
Jun 09, 16:00
16.96
0.00 (0.00%)
After-Hours: 19:00
Caris Life Sciences EPS Diluted (Quarterly) : -0.0018 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Natera, Inc. | -0.6013 |
| Myriad Genetics, Inc. | -0.3639 |
| BioRestorative Therapies, Inc. | -0.1215 |
| CareDx, Inc. | 0.0529 |
| Exagen, Inc. | -0.1663 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.51M |
| Revenue (Quarterly) | 216.17M |
| Total Expenses (Quarterly) | 216.68M |
| Enterprise Value | 4.169B |
| Gross Profit Margin (Quarterly) | 65.39% |
| Profit Margin (Quarterly) | -0.24% |
| Earnings Yield | -8.64% |
| Operating Earnings Yield | 2.26% |
| Normalized Earnings Yield | -8.056 |